Tinocef
100 mg/5 ml
Cefixime
Segment 05 · Cephalosporins
Tinocef100 mg/5 ml
Cefixime
Also marketed as Cefi in selected markets
Tinocef
100 mg/5 ml
Cefixime
Third generation cephalosporin for respiratory, urinary and enteric infections.
Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation
- Generic composition
- Cefixime
- Strength
- 100 mg/5 ml
- Dosage form
- Dry Suspension
- Pack sizes
- 30 ml, 60 ml
Other forms & strengths of Tinocef
- Manufacturer
- Paramount Pharmaceuticals, Islamabad
- Licence
- DML 000439 · DRAP GMP
- Release
- Batch-tested, with Certificate of Analysis
For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.
Tinocef
How it's made
Dry suspensions are made as a dry powder blend, filled into bottles; water is added only when the medicine is dispensed. Made in the segregated cephalosporin section, which has its own air handling and material flows.
How all our dosage forms are made →- 01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
- 02
Dry blending
The active ingredient is blended with sweeteners, flavour and suspending agents as a dry powder.
- 03
Powder filling
Bottles are filled to a set powder weight; water is added only by the pharmacist or patient.
- 04
Capping and labelling
Bottles are sealed and labelled with the batch number and expiry date.
Batch release tests
- Fill weight
- Assay of the active ingredient
- Reconstitution and pH
- Water content
- Microbial limits
Limits for this product are on each batch's Certificate of Analysis.